EDMONTON, ALBERTA--(Marketwire - 12 déc. 2011) - Afexa Life Sciences Inc. (« Afexa » ou la « Société ») (TSX:FXA)...

print release     

EDMONTON, ALBERTA--(Marketwire - Dec. 12, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) announced today that at its special meeting of shareholders held...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - 16 nov. 2011) - Afexa Life Sciences Inc. (« Afexa » ou la « Société ») (TSX:FXA) a annoncé...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Nov. 16, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) announced today that it has mailed to its...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Nov. 11, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) today announced that during the quarter ended September 30, 2011 revenue of $15.0 million was achieved,...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Oct. 27, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - announced today that it has been advised...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Oct. 18, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - announced today that Robert Chai-Onn, Executive Vice President,...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Oct. 18, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - announced today that it has been advised by 1625907 Alberta Ltd. (the "Offeror"), a...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Oct. 4, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - announced today that it has filed a notice...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Sept. 30, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - announced today that it has entered...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Sept. 28, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - announced today that Paladin Labs Inc. ("Paladin") has amended...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Sept. 22, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - responded to a news release issued today...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Sept. 9, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - today announced that its Board of...

print release        pdf  

KINGSTON, ONTARIO--(Marketwire - Sept. 6, 2011) -

Attention medical writers/reporters; business reporters; education reporters

Queen's University medical researchers today released the first report of its...

print release        pdf  

TORONTO, ONTARIO--(Marketwire - Aug. 31, 2011) -

Attention: Medical and Business Editors 

Afexa Life Sciences Inc.("Afexa" or the "Company") (TSX:FXA) today officially launched...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 30, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA)- the maker of COLD-FX^®- today announced that it has entered into a definitive acquisition support agreement...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 26, 2011) - Afexa Life Sciences Inc. (TSX:FXA) today announced the encouraging results of an interim analysis performed by an independent data monitoring committee (IDMC) for the...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 23, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - today announced that its Board of Directors (the "Board")...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 19, 2011) -

• First quarter results improve over last year
• Product...
  
  print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 18, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - today announced promising results of a pilot clinical study...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 17, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - announces that it has been notified by...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 14, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® - has adopted a new shareholder rights plan (the "New Rights Plan"). The New...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 10, 2011) - Afexa Life Sciences Inc. ("Afexa" or "the Company") (TSX:FXA) outlined today at their shareholders Annual General Meeting ("AGM") the progress the Company is making towards...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Aug. 10, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX(R) – was today advised that Paladin Labs Inc. ("Paladin") has filed documents with Canadian...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - July 18, 2011) - Afexa Life Sciences Inc. (TSX:FXA) today announced the U.S. Food and Drug Administration (FDA) authorization of a Phase 1B clinical trial of AFX-2 (CVT-E002™) as an...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - July 18, 2011) - Afexa Life Sciences Inc. (TSX:FXA)

On Friday, July 15, 2011, after market close, Paladin Labs Inc. announced in a news release that they had purchased 14.94% of Afexa's...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - June 24, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) - the maker of COLD-FX^® – today announced that the Human Resources and Compensation Committee of the...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - June 23, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA), maker of COLD-FX^®, announced the appointment of Annalisa King, Senior Vice President and CFO of Best...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - June 10, 2011) - Afexa Life Sciences Inc. ("Afexa" or "the Company") (TSX:FXA) today announced its financial results for the year ended March 31, 2011. 

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - June 2, 2011) - Afexa Life Sciences Inc. (TSX:FXA) - the maker of COLD-FX^® – today announced results of a clinical trial exploring the potential application of...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - March 31, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA) today announced the appointment of William B. White as Independent Chairman of the Board of Directors of Afexa, effective...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Feb. 11, 2011) - Afexa Life Sciences Inc. ("Afexa" or "the Company") (TSX:FXA) today announced its financial results for the three months ended December 31, 2010. 

EDMONTON, ALBERTA--(Marketwire - Jan. 21, 2011) - Afexa Life Sciences Inc. ("Afexa" or the "Company") (TSX:FXA), maker of COLD-FX, announced that Ms. Tracey Ramsay has agreed to join the Company,...

print release        pdf  

EDMONTON, ALBERTA--(Marketwire - Jan. 19, 2011) - Afexa Life Sciences Inc. ("Afexa") (TSX:FXA) wishes to set the record straight. After a thorough review of our contractual arrangements and other dealings with Alberta Health...

print release        pdf